Navigation Links
Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin
Date:11/6/2007

SUNNYVALE, Calif., Nov. 6 /PRNewswire/ -- Pathwork Diagnostics, a genomics-based diagnostics company focused on oncology, announced today that Virginia Commonwealth University School of Medicine has initiated an investigational study of the Pathwork(TM) Tissue of Origin Test. The new genomics-based test is designed to help determine a tumor's origin so that tissue-specific management can begin. VCU's study makes it one of the first institutions in the country to evaluate this leading technology in patients who may have few remaining diagnostic options. The Tissue of Origin Test is also the focus of two workshops and two poster presentations at the 12th Annual Meeting of the Association for Molecular Pathology this week (November 7-10, Los Angeles).

"Patient cases in which a tumor cannot be readily identified are a significant problem," said Catherine Dumur, Ph.D., Director of Molecular Morphology Genomics for the Department of Pathology, VCU. "Such cases are time-consuming for physicians and anxiety-producing for patients, and are a challenge to providing the most appropriate care for the patient. We are eager to see how this investigational new genomics-based test extends and complements traditional histopathological approaches."

There are an estimated 200,000 cancer patients each year in the United States who may benefit from additional diagnostic information to determine the tissue of origin for their cancer. National Comprehensive Cancer Network guidelines emphasize the importance of identifying the tissue of origin so that management specific to the primary cancer can begin.

"We envision that in the future genomics data will become a useful ancillary tool to pathologists to answer complex cancer questions in a clinical setting," said Carleton Garrett, M.D. Ph.D., Director of the Tissue and Data Acquisition and Analysis Core at VCU. "Virginia Commonwealth University will continue to evaluate the use of such innovative technologies in ord
'/>"/>

SOURCE Pathwork Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ntly announced that Dr. Dominique Hebrault will pr...nalytical Technology (PAT) in Green Chemistry and ... (PRWEB) November 20, 2009 -...ology (PAT) in Green Chemistry and Green Engineeri...nology (PAT) case studies will be presented on how...
(Date:11/19/2009)...Call/ -- Omeros Corporation (Nasdaq: OMER ) today...rd quarter ended September 30, 2009. For the three...a net loss of $3.9 million, or $1.34 per share, as...per share, for the same period in 2008. For the ni...ported a net loss of $15.5 million, or $5.29 per s...
(Date:11/19/2009)...tCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), announ... its shareholders, discussing the Company,s acquis...icals Holdings, Inc. (CHBP), an integrated bio-pha... of China. The merger gives NeoStem a controlling ...., CHBP,s primary operating subsidiary and a promi...
(Date:11/19/2009)...19 MONITORING FORCE GmbH,announced...nserin in the,indication treatment-relevant levodo...rphan drug status designation with the European Me... is a complication of the mainstay,treatment in ad... those,affected, since it may be disabling for the...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... TSX Exchange Symbol: RVX, CALGARY, Apri...Resverlogix" or the "Company") (TSX:RVX) announced...a safety, tolerability and pharmacokinetics,study ...ses the,dyslipidemia market. "Initial results from... J. McCaffrey, President & CEO of Resverlogix. "As...
...SM), a developer of follow-on biologics (FOBs) and...Allan, Ph.D., CEO of Insmed, will present at,the C...n FOBs, on April 29,2008 at 2:15 PM Eastern Time i..."Evaluate the Legislative, Economic and,Scientific...rs and,Follow-On Biologics," will be held at the D...
...oterrorism, Says UK Board Mem...fense Corp., the only company in,the world to deve...destroy,a biohazardous substance while maintaining...ounced it has partnered with General Lord Guthrie,...blish new security,markets for the BioDefense Mail...
Other Biology Technology:Dosing for RVX-208 Phase 1a Clinical Study Completed 2Insmed to Present at CBI Follow-On Biologics Conference 2Insmed to Present at CBI Follow-On Biologics Conference 3Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 2Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 3
(Date:11/22/2009)...h Centre, a partnership of the University of Briti...tal Health Research Institute, have uncovered new ...ls die following a stroke, as well as a possible w...dy were recently published online in Nature Medic...tinue to die even after blood flow has been restor...
(Date:11/20/2009)...ad studies about the health benefits of having a l...ar level, where amino acids known as cysteines are...hen paired up with other cysteines. , Now, resea...olleagues in Belgium, have discovered a new antiox...esearch appears in the Nov. 20 issue of the journa...
(Date:11/20/2009)...9) Scientists from the Marine Biogeochemistry and...arch Laboratory (NRL) organized and led a team of ...expedition to initiate methane hydrate exploration...iation of sediment contribution to Arctic climate ...Polar Sea as a research platform, three cross-shel...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 1100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 1ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 2ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 4Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 1Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 2Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 3
...dentified the proteins that allow specific brain c...aks what can come into the cell. The findings, des...researchers harness the process, perhaps one day u...disease. , Much as turning the television dial cha...cells are able to change what they allow in by swa...
...eaded by Professor Hans-Georg Kräusslich at Heidel...Hanswalter Zentgraf, Division of Applied Tumor Vir...man Cancer Research Center, DKFZ), have been the f... for visual investigations without inhibiting the ...beling permits scientists to observe the behavior ...
... secreted by mussels and a polymer that repels cel...rsity have designed a versatile new two-sided coat... , Currently the longevity of certain medical imp... in the body gradually accumulate on the devices (...and threatening patients with infections. Unfortun...
Other Biology News:Some Brain Cells Change Channels 2Some Brain Cells Change Channels 3New Species of Coral Discovered Off Southern California 2Innovative coating could give medical implants a longer life 2
Chaperone Sampler Kit from BD Biosciences Pharmingen
SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen
Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend
Caveolin Sampler Kit from BD Biosciences Pharmingen
Biology Products: